Cargando…
Human helminth therapy to treat inflammatory disorders- where do we stand?
Parasitic helminths have evolved together with the mammalian immune system over many millennia and as such they have become remarkably efficient modulators in order to promote their own survival. Their ability to alter and/or suppress immune responses could be beneficial to the host by helping contr...
Autor principal: | Helmby, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374592/ https://www.ncbi.nlm.nih.gov/pubmed/25884706 http://dx.doi.org/10.1186/s12865-015-0074-3 |
Ejemplares similares
Ejemplares similares
-
ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011) -
Potential biomarkers for bipolar disorder: Where do we stand?
por: Sagar, Rajesh, et al.
Publicado: (2017) -
Where Do We Stand?
Publicado: (1891) -
Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012) -
Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)